Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0506AT07 GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1336.86 C68H124N2O23
LMSP0506AK06 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1732.04 C84H153N3O33
LMSP0506AT08 GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1364.89 C70H128N2O23
LMSP0506BI07 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1686 C82H147N3O32
LMSP0506BD05 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1297.85 C66H123NO23
LMSP0506AO04 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1513.92 C74H135N3O28
LMSP0506AU01 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1388.8 C66H120N2O28
LMSP0506AI04 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1879.06 C88H158N4O38
LMSP0506BA03 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1606.92 C76H138N2O33
LMSP0506AM03 Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1647.94 C78H141N3O33
LMSP0506AU05 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1500.93 C74H136N2O28
LMSP0506BF08 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1364.89 C70H128N2O23
LMSP0506BJ08 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1876.08 C90H161N3O37
LMSP0506AA08 Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1307.87 C68H125NO22
LMSP0506AH01 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1998.04 C90H159N5O43
LMSP0506BC06 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1837.07 C88H160N2O37
LMSP0506BC05 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1809.04 C86H156N2O37
LMSP0506AM08 Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1730.02 C84H151N3O33
LMSP0506AM07 Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1701.99 C82H147N3O33
LMSP0506BC04 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1781.01 C84H152N2O37
LMSP0506BC03 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1752.98 C82H148N2O37
LMSP0506AJ06 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1935.12 C92H166N4O38
LMSP0506AT02 GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1254.78 C62H114N2O23
LMSP0506BD04 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1269.82 C64H119NO23
LMSP0506AZ04 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1253.82 C64H119NO22
LMSP0506BJ05 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1850.07 C88H159N3O37
LMSP0507AA06 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1163.83 C62H117NO18
LMSP0507AA05 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1135.8 C60H113NO18
LMSP0507AA04 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1107.76 C58H109NO18
LMSP0507AA01 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1023.67 C52H97NO18
LMSP0507AA07 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1133.78 C60H111NO18
LMSP0507AA08 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1161.81 C62H115NO18
LMSP0507AA02 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1051.7 C54H101NO18
LMSP0507AA03 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1079.73 C56H105NO18
LMSP0508AA04 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1148.79 C60H112N2O18
LMSP0508AA05 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1176.82 C62H116N2O18
LMSP0508AA06 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1204.85 C64H120N2O18
LMSP0508AA01 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1064.7 C54H100N2O18
LMSP0508AA03 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1120.76 C58H108N2O18
LMSP0508AA07 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1174.81 C62H114N2O18
LMSP0508AA02 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1092.73 C56H104N2O18
LMSP0508AA08 GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) [SP0508] 1202.84 C64H118N2O18
LMSP0509AA07 Galalpha1-4Galbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 971.73 C54H101NO13
LMSP0509AA06 Galalpha1-4Galbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 1001.77 C56H107NO13
LMSP0509AA05 Galalpha1-4Galbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 973.74 C54H103NO13
LMSP0509AA08 Galalpha1-4Galbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 999.76 C56H105NO13
LMSP0509AA03 Galalpha1-4Galbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 917.68 C50H95NO13
LMSP0509AA02 Galalpha1-4Galbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 889.65 C48H91NO13
LMSP0509AA01 Galalpha1-4Galbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 861.62 C46H87NO13
LMSP0509AA04 Galalpha1-4Galbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Gal- (Gala series) [SP0509] 945.71 C52H99NO13